Epidemiological Characterizations of Class 1 Integrons from Multidrug-Resistant Acinetobacter Isolates in Daejeon, Korea

Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type a...

Full description

Saved in:
Bibliographic Details
Published inAnnals of laboratory medicine Vol. 34; no. 4; pp. 293 - 299
Main Authors Sung, Ji Youn, Koo, Sun Hoe, Kim, Semi, Kwon, Kye Chul
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society for Laboratory Medicine 01.07.2014
대한진단검사의학회
Subjects
Online AccessGet full text
ISSN2234-3806
2234-3814
2234-3814
DOI10.3343/alm.2014.34.4.293

Cover

Abstract Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods. Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing. Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria. Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates.
AbstractList Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods. Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing. Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria. Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates.
Background: Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent- resistance genes via class 1 integrons. In this study, integrons were characterized to inves- tigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addi- tion, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods. Methods: Fifty-six MDR Acinetobacter spp.- A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory con- centrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palin- dromic sequence (REP)-PCR were performed for epidemiological typing. Results: Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A ( aacA4 - catB8 - aadA1 ), 3.0-kb type B ( aacA4 - blaI MP-1 - bla OXA-2 ), 3.0-kb type C ( bla VIM-2 - aacA7 - aadA1 ), and 1.8-kb type D ( aac3 - 1 - bla OXA-2 - orfD ). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. bauman- nii isolates, regardless of clone and separation time of the bacteria. Conclusions: Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non- baumannii Acinetobacter isolates. KCI Citation Count: 8
Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods.BACKGROUNDMultidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods.Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing.METHODSFifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing.Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria.RESULTSClass 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria.Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates.CONCLUSIONSAlthough class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates.
Author Koo, Sun Hoe
Kwon, Kye Chul
Sung, Ji Youn
Kim, Semi
AuthorAffiliation 1 Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea
2 Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
AuthorAffiliation_xml – name: 1 Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea
– name: 2 Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
Author_xml – sequence: 1
  givenname: Ji Youn
  surname: Sung
  fullname: Sung, Ji Youn
  organization: Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea
– sequence: 2
  givenname: Sun Hoe
  surname: Koo
  fullname: Koo, Sun Hoe
  organization: Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
– sequence: 3
  givenname: Semi
  surname: Kim
  fullname: Kim, Semi
  organization: Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
– sequence: 4
  givenname: Kye Chul
  surname: Kwon
  fullname: Kwon, Kye Chul
  organization: Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24982834$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001886898$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kktv1DAUhSNUREvpD2CDvGRBgl_JxBuk0bTAiCKkqqytG-dm6taxB9tBwK8nM0PLQ8Kba9nfOWdxz9PiyAePRfGc0UoIKV6DGytOmayErGTFlXhUnHAuZClaJo8e7rQ5Ls5SuqXzaSjjij4pjrlULW-FPCm-XWxtj6MNLmysAUdWNxDBZIz2B2QbfCJhICsHKRFG1j7jJu4ehxhG8nFy2fZx2pRXmGzK4DNZGusxh27vQdYpOMiYiPXkHPAWg39FPoSI8Kx4PIBLePZrnhaf315cr96Xl5_erVfLy9JIwXOJdW1oJ1XdtbzvFSgQ2DBKoR2gkUph1zesGbpuIZAhXyhssAcjVE1bwQ0Vp8XLg6-Pg74zVgew-7kJ-i7q5dX1WjPJqWxm9M0B3U7diL1BnyM4vY12hPh9L_z7x9ub2earlnTBWNv8ztrG8GXClPVok0HnwGOYkma15FypRatm9MWfWQ8h95uZgcUBMDGkFHHQxub9RuZo6zSjelcDPddA72qghdRSzzWYlewf5b35_zU_AV73t_o
CitedBy_id crossref_primary_10_3390_ijms22158080
crossref_primary_10_1099_jmm_0_000315
crossref_primary_10_1007_s11356_017_0945_7
crossref_primary_10_1097_MRM_0000000000000270
crossref_primary_10_5812_jjm_13100
crossref_primary_10_1080_1120009X_2015_1133014
crossref_primary_10_3389_fmicb_2016_00049
crossref_primary_10_1016_j_ijfoodmicro_2019_01_015
crossref_primary_10_1089_mdr_2019_0210
crossref_primary_10_1089_mdr_2020_0442
crossref_primary_10_1186_s12866_023_03049_8
crossref_primary_10_1016_j_joad_2016_08_004
crossref_primary_10_31631_2073_3046_2018_17_3_27_31
crossref_primary_10_1186_s12879_016_1526_y
Cites_doi 10.1371/journal.pone.0010034
10.3349/ymj.2013.54.1.177
10.1016/j.mimet.2005.02.007
10.1046/j.1469-0691.2000.00181.x
10.1097/01.qco.0000171920.44809.f0
10.1099/jmm.0.45716-0
10.1128/JCM.00014-08
10.3343/kjlm.2011.31.4.265
10.1128/JCM.00967-09
10.1186/1476-0711-8-21
10.1128/JCM.01759-12
10.1586/14787210.6.3.309
10.1099/mic.0.026054-0
10.1086/529198
10.1016/j.ijantimicag.2011.08.006
10.1128/JCM.43.9.4382-4390.2005
10.1093/jac/dkn179
10.1128/JCM.02373-10
10.1128/AAC.45.9.2658-2661.2001
10.1128/AAC.01728-10
10.1016/j.ijantimicag.2012.05.017
10.3389/fmicb.2012.00148
10.1016/j.diagmicrobio.2009.02.010
10.1128/AAC.46.11.3665-3668.2002
10.1093/clinids/22.6.1026
10.1038/nrmicro1462
10.1146/annurev-genet-102209-163504
10.1016/j.ijantimicag.2009.11.020
10.1128/JCM.43.7.3074-3082.2005
ContentType Journal Article
Copyright The Korean Society for Laboratory Medicine. 2014
Copyright_xml – notice: The Korean Society for Laboratory Medicine. 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3343/alm.2014.34.4.293
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-3814
EndPage 299
ExternalDocumentID oai_kci_go_kr_ARTI_142046
PMC4071186
24982834
10_3343_alm_2014_34_4_293
Genre Journal Article
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
C~G
DIK
DYU
EF.
GX1
HYE
KQ8
M48
PGMZT
RPM
CGR
CUY
CVF
ECGQY
ECM
EIF
EMOBN
NPM
7X8
5PM
M~E
OK1
OZF
ID FETCH-LOGICAL-c432t-e55c0b495b82dd9a9a3e6100a8fa6499ebd616fbb73e1e279e6edac3950832c03
IEDL.DBID M48
ISSN 2234-3806
2234-3814
IngestDate Tue Nov 21 21:41:27 EST 2023
Thu Aug 21 18:02:31 EDT 2025
Thu Jul 10 16:30:42 EDT 2025
Thu Apr 03 07:05:57 EDT 2025
Tue Jul 01 03:11:32 EDT 2025
Thu Apr 24 23:01:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Sequence types
MDR Acinetobacter spp
MLST
Integron
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c432t-e55c0b495b82dd9a9a3e6100a8fa6499ebd616fbb73e1e279e6edac3950832c03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000327.2014.34.4.011
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3343/alm.2014.34.4.293
PMID 24982834
PQID 1542299789
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_142046
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4071186
proquest_miscellaneous_1542299789
pubmed_primary_24982834
crossref_citationtrail_10_3343_alm_2014_34_4_293
crossref_primary_10_3343_alm_2014_34_4_293
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-07-01
PublicationDateYYYYMMDD 2014-07-01
PublicationDate_xml – month: 07
  year: 2014
  text: 2014-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Annals of laboratory medicine
PublicationTitleAlternate Ann Lab Med
PublicationYear 2014
Publisher The Korean Society for Laboratory Medicine
대한진단검사의학회
Publisher_xml – name: The Korean Society for Laboratory Medicine
– name: 대한진단검사의학회
References Srinivasan (10.3343/alm.2014.34.4.293_ref16) 2009; 8
Park (10.3343/alm.2014.34.4.293_ref28) 2012; 39
Cambray (10.3343/alm.2014.34.4.293_ref10) 2010; 44
Da Silva (10.3343/alm.2014.34.4.293_ref11) 2002; 215
Clinical and Laboratory Standards Institute (10.3343/alm.2014.34.4.293_ref18) 2010
White (10.3343/alm.2014.34.4.293_ref20) 2001; 45
van den Broek (10.3343/alm.2014.34.4.293_ref7) 2009; 47
Golanbar (10.3343/alm.2014.34.4.293_ref25) 2011; 49
Roca (10.3343/alm.2014.34.4.293_ref31) 2012; 3
Cisneros (10.3343/alm.2014.34.4.293_ref3) 1996; 22
Bartual (10.3343/alm.2014.34.4.293_ref22) 2005; 43
Higgins (10.3343/alm.2014.34.4.293_ref29) 2012; 50
Gundi (10.3343/alm.2014.34.4.293_ref17) 2009; 155
Machado (10.3343/alm.2014.34.4.293_ref9) 2008; 62
Gombac (10.3343/alm.2014.34.4.293_ref12) 2002; 46
Diancourt (10.3343/alm.2014.34.4.293_ref21) 2010; 5
Wu (10.3343/alm.2014.34.4.293_ref24) 2012; 40
Nemec (10.3343/alm.2014.34.4.293_ref13) 2004; 53
Gootz (10.3343/alm.2014.34.4.293_ref8) 2008; 6
Turton (10.3343/alm.2014.34.4.293_ref26) 2005; 43
Maragakis (10.3343/alm.2014.34.4.293_ref1) 2008; 46
Mazel (10.3343/alm.2014.34.4.293_ref14) 2006; 4
Lin (10.3343/alm.2014.34.4.293_ref27) 2010; 35
Dillon (10.3343/alm.2014.34.4.293_ref19) 2005; 62
Ko (10.3343/alm.2014.34.4.293_ref6) 2008; 46
Esterly (10.3343/alm.2014.34.4.293_ref5) 2011; 55
Navon-Venezia (10.3343/alm.2014.34.4.293_ref2) 2005; 18
Park (10.3343/alm.2014.34.4.293_ref30) 2013; 54
Cho (10.3343/alm.2014.34.4.293_ref15) 2009; 64
Sung (10.3343/alm.2014.34.4.293_ref4) 2011; 31
Bou (10.3343/alm.2014.34.4.293_ref23) 2000; 6
16145081 - J Clin Microbiol. 2005 Sep;43(9):4382-90
22895032 - J Clin Microbiol. 2012 Nov;50(11):3493-500
20707672 - Annu Rev Genet. 2010;44:141-66
20106635 - Int J Antimicrob Agents. 2010 May;35(5):439-43
12393197 - FEMS Microbiol Lett. 2002 Sep 24;215(1):33-9
21825287 - Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9
15985826 - Curr Opin Infect Dis. 2005 Aug;18(4):306-13
16009279 - J Microbiol Methods. 2005 Aug;62(2):221-32
19389786 - Microbiology. 2009 Jul;155(Pt 7):2333-41
21996405 - Int J Antimicrob Agents. 2012 Jan;39(1):81-5
20383326 - PLoS One. 2010;5(4):e10034
11284921 - Clin Microbiol Infect. 2000 Dec;6(12):635-43
19361944 - Diagn Microbiol Infect Dis. 2009 Jun;64(2):185-90
22016680 - Korean J Lab Med. 2011 Oct;31(4):265-70
15585503 - J Med Microbiol. 2004 Dec;53(Pt 12):1233-40
12384388 - Antimicrob Agents Chemother. 2002 Nov;46(11):3665-8
18385442 - J Clin Microbiol. 2008 Jun;46(6):2052-9
18588496 - Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25
22817917 - Int J Antimicrob Agents. 2012 Sep;40(3):264-7
16000417 - J Clin Microbiol. 2005 Jul;43(7):3074-82
8783704 - Clin Infect Dis. 1996 Jun;22(6):1026-32
23225816 - Yonsei Med J. 2013 Jan 1;54(1):177-82
19794057 - J Clin Microbiol. 2009 Nov;47(11):3593-9
19531268 - Ann Clin Microbiol Antimicrob. 2009;8:21
16845431 - Nat Rev Microbiol. 2006 Aug;4(8):608-20
11502548 - Antimicrob Agents Chemother. 2001 Sep;45(9):2658-61
22536199 - Front Microbiol. 2012 Apr 23;3:148
18456652 - J Antimicrob Chemother. 2008 Aug;62(2):296-302
21450955 - J Clin Microbiol. 2011 Jun;49(6):2121-31
18444865 - Clin Infect Dis. 2008 Apr 15;46(8):1254-63
References_xml – volume: 5
  start-page: e10034
  year: 2010
  ident: 10.3343/alm.2014.34.4.293_ref21
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010034
– volume: 54
  start-page: 177
  year: 2013
  ident: 10.3343/alm.2014.34.4.293_ref30
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2013.54.1.177
– volume: 62
  start-page: 221
  year: 2005
  ident: 10.3343/alm.2014.34.4.293_ref19
  publication-title: J Microbiol Methods
  doi: 10.1016/j.mimet.2005.02.007
– volume: 6
  start-page: 635
  year: 2000
  ident: 10.3343/alm.2014.34.4.293_ref23
  publication-title: Clin Microbiol Infect
  doi: 10.1046/j.1469-0691.2000.00181.x
– volume: 18
  start-page: 306
  year: 2005
  ident: 10.3343/alm.2014.34.4.293_ref2
  publication-title: Curr Opin Infect Dis
  doi: 10.1097/01.qco.0000171920.44809.f0
– volume: 53
  start-page: 1233
  year: 2004
  ident: 10.3343/alm.2014.34.4.293_ref13
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.45716-0
– volume: 46
  start-page: 2052
  year: 2008
  ident: 10.3343/alm.2014.34.4.293_ref6
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00014-08
– volume: 31
  start-page: 265
  year: 2011
  ident: 10.3343/alm.2014.34.4.293_ref4
  publication-title: Korean J Lab Med
  doi: 10.3343/kjlm.2011.31.4.265
– volume: 47
  start-page: 3593
  year: 2009
  ident: 10.3343/alm.2014.34.4.293_ref7
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00967-09
– volume: 8
  start-page: 21
  year: 2009
  ident: 10.3343/alm.2014.34.4.293_ref16
  publication-title: Ann Clin Microbiol Antimicrob
  doi: 10.1186/1476-0711-8-21
– volume: 50
  start-page: 3493
  year: 2012
  ident: 10.3343/alm.2014.34.4.293_ref29
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01759-12
– volume: 6
  start-page: 309
  year: 2008
  ident: 10.3343/alm.2014.34.4.293_ref8
  publication-title: Expert Rev Anti Infect Ther
  doi: 10.1586/14787210.6.3.309
– volume: 155
  start-page: 2333
  year: 2009
  ident: 10.3343/alm.2014.34.4.293_ref17
  publication-title: Microbiology
  doi: 10.1099/mic.0.026054-0
– volume: 46
  start-page: 1254
  year: 2008
  ident: 10.3343/alm.2014.34.4.293_ref1
  publication-title: Clin Infect Dis
  doi: 10.1086/529198
– volume: 39
  start-page: 81
  year: 2012
  ident: 10.3343/alm.2014.34.4.293_ref28
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2011.08.006
– volume: 43
  start-page: 4382
  year: 2005
  ident: 10.3343/alm.2014.34.4.293_ref22
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.9.4382-4390.2005
– volume: 62
  start-page: 296
  year: 2008
  ident: 10.3343/alm.2014.34.4.293_ref9
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkn179
– volume: 49
  start-page: 2121
  year: 2011
  ident: 10.3343/alm.2014.34.4.293_ref25
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02373-10
– volume: 45
  start-page: 2658
  year: 2001
  ident: 10.3343/alm.2014.34.4.293_ref20
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.45.9.2658-2661.2001
– volume: 55
  start-page: 4844
  year: 2011
  ident: 10.3343/alm.2014.34.4.293_ref5
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01728-10
– volume: 40
  start-page: 264
  year: 2012
  ident: 10.3343/alm.2014.34.4.293_ref24
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2012.05.017
– volume: 3
  start-page: 148
  year: 2012
  ident: 10.3343/alm.2014.34.4.293_ref31
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2012.00148
– volume: 64
  start-page: 185
  year: 2009
  ident: 10.3343/alm.2014.34.4.293_ref15
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2009.02.010
– volume-title: Performance standards for antimicrobial susceptibility testing. Twentieth Informational supplement, M100-S20
  year: 2010
  ident: 10.3343/alm.2014.34.4.293_ref18
– volume: 46
  start-page: 3665
  year: 2002
  ident: 10.3343/alm.2014.34.4.293_ref12
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.46.11.3665-3668.2002
– volume: 22
  start-page: 1026
  year: 1996
  ident: 10.3343/alm.2014.34.4.293_ref3
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/22.6.1026
– volume: 4
  start-page: 608
  year: 2006
  ident: 10.3343/alm.2014.34.4.293_ref14
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro1462
– volume: 44
  start-page: 141
  year: 2010
  ident: 10.3343/alm.2014.34.4.293_ref10
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-102209-163504
– volume: 215
  start-page: 33
  year: 2002
  ident: 10.3343/alm.2014.34.4.293_ref11
  publication-title: FEMS Microbiol Lett
– volume: 35
  start-page: 439
  year: 2010
  ident: 10.3343/alm.2014.34.4.293_ref27
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2009.11.020
– volume: 43
  start-page: 3074
  year: 2005
  ident: 10.3343/alm.2014.34.4.293_ref26
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.7.3074-3082.2005
– reference: 20106635 - Int J Antimicrob Agents. 2010 May;35(5):439-43
– reference: 18456652 - J Antimicrob Chemother. 2008 Aug;62(2):296-302
– reference: 16845431 - Nat Rev Microbiol. 2006 Aug;4(8):608-20
– reference: 23225816 - Yonsei Med J. 2013 Jan 1;54(1):177-82
– reference: 19531268 - Ann Clin Microbiol Antimicrob. 2009;8:21
– reference: 21996405 - Int J Antimicrob Agents. 2012 Jan;39(1):81-5
– reference: 20707672 - Annu Rev Genet. 2010;44:141-66
– reference: 11284921 - Clin Microbiol Infect. 2000 Dec;6(12):635-43
– reference: 8783704 - Clin Infect Dis. 1996 Jun;22(6):1026-32
– reference: 22817917 - Int J Antimicrob Agents. 2012 Sep;40(3):264-7
– reference: 15585503 - J Med Microbiol. 2004 Dec;53(Pt 12):1233-40
– reference: 22536199 - Front Microbiol. 2012 Apr 23;3:148
– reference: 19361944 - Diagn Microbiol Infect Dis. 2009 Jun;64(2):185-90
– reference: 22895032 - J Clin Microbiol. 2012 Nov;50(11):3493-500
– reference: 12384388 - Antimicrob Agents Chemother. 2002 Nov;46(11):3665-8
– reference: 12393197 - FEMS Microbiol Lett. 2002 Sep 24;215(1):33-9
– reference: 21825287 - Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9
– reference: 20383326 - PLoS One. 2010;5(4):e10034
– reference: 18588496 - Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25
– reference: 11502548 - Antimicrob Agents Chemother. 2001 Sep;45(9):2658-61
– reference: 15985826 - Curr Opin Infect Dis. 2005 Aug;18(4):306-13
– reference: 19794057 - J Clin Microbiol. 2009 Nov;47(11):3593-9
– reference: 16000417 - J Clin Microbiol. 2005 Jul;43(7):3074-82
– reference: 18385442 - J Clin Microbiol. 2008 Jun;46(6):2052-9
– reference: 18444865 - Clin Infect Dis. 2008 Apr 15;46(8):1254-63
– reference: 16145081 - J Clin Microbiol. 2005 Sep;43(9):4382-90
– reference: 21450955 - J Clin Microbiol. 2011 Jun;49(6):2121-31
– reference: 22016680 - Korean J Lab Med. 2011 Oct;31(4):265-70
– reference: 19389786 - Microbiology. 2009 Jul;155(Pt 7):2333-41
– reference: 16009279 - J Microbiol Methods. 2005 Aug;62(2):221-32
SSID ssj0000601290
Score 2.0555556
Snippet Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to...
Background: Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent- resistance genes via class 1 integrons. In this study, integrons were...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 293
SubjectTerms Acinetobacter - drug effects
Acinetobacter - isolation & purification
Acinetobacter - metabolism
Acinetobacter baumannii - drug effects
Acinetobacter baumannii - isolation & purification
Acinetobacter baumannii - metabolism
Acinetobacter Infections - epidemiology
Acinetobacter Infections - microbiology
Anti-Bacterial Agents - pharmacology
DNA, Bacterial - chemistry
DNA, Bacterial - metabolism
Drug Resistance, Multiple, Bacterial
Humans
Integrons - genetics
Microbial Sensitivity Tests
Multilocus Sequence Typing
Original
Polymerase Chain Reaction
Republic of Korea
병리학
Title Epidemiological Characterizations of Class 1 Integrons from Multidrug-Resistant Acinetobacter Isolates in Daejeon, Korea
URI https://www.ncbi.nlm.nih.gov/pubmed/24982834
https://www.proquest.com/docview/1542299789
https://pubmed.ncbi.nlm.nih.gov/PMC4071186
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001886898
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Laboratory Medicine, 2014, 34(4), , pp.293-299
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELa2i4S4IN6Ux8pInBAuduw4yQGh1bLLFlQOiEq9WfEju2UrB9JWWv49M0laKKqQOEVJHDvx52S-L_bMEPLSZ0JV3FdMyswzJXjBcmVLJhTctgva8hSdkyef9flUfZylswOySW_Vd-Byr7TDfFLTZjG6_vHzHbzwb1FxSiXflAt0KRdqJNVIjcB-DcgNMEwatdikZ_vdh3nz1wVsomIy57qb59xfy46lGsSm2kdC_15L-YdxOrtDbveskh53w-AuOQjxHrk56efN75Pr09-JYBEVerKN09y7YdK6om2CTCrouA0hgQfR-YS2Prq-WV-wL2GJdDOu6DHWi98CrIOOYQAjZ6XzSN-X4Vuo42v6qQY--oBMz06_npyzPucCc0omKxbS1HELqsnmifdFWZQyAMPiZV6VGtRRsF4LXVmbySBCkhVBB186iclkZeK4fEgOYx3DY0JVmtqQAYHIZKVcmhSOB62DcD7PfcHtkPBN_xrXByTHvBgLA8IEITEAiUFIjFRGGYBkSF5tL_neReP4V-EXAJq5cnODMbRxe1Gbq8aAUhiD5Em40lBmA6mB9wonS8oY6vXSALVMwFRneTEkjzqIt02CZAWhKtWQZDvgbwtge7tn4vyyjd2N-lnk-sn_PMhTcgv3u0XCz8jhqlmH50CFVvaIDD7MxFE7zH8BpwYHow
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiological+Characterizations+of+Class+1+Integrons+from+Multidrug-Resistant+Acinetobacter+Isolates+in+Daejeon%2C+Korea&rft.jtitle=Annals+of+laboratory+medicine&rft.au=Sung%2C+Ji+Youn&rft.au=Koo%2C+Sun+Hoe&rft.au=Kim%2C+Semi&rft.au=Kwon%2C+Kye+Chul&rft.date=2014-07-01&rft.issn=2234-3806&rft.eissn=2234-3814&rft.volume=34&rft.issue=4&rft.spage=293&rft.epage=299&rft_id=info:doi/10.3343%2Falm.2014.34.4.293&rft.externalDBID=n%2Fa&rft.externalDocID=10_3343_alm_2014_34_4_293
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon